S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis
Chiara Camponeschi(Università Cattolica del Sacro Cuore), Gabriele Di Sante(University of Perugia), Beatrice Sampaolese(Institute of Chemistry of Molecular Recognition), Maria Elisabetta Clementi(Tecnologie Avanzate (Italy)), Maria Tredicine(Università Cattolica del Sacro Cuore), Fabrizio Michetti(Foro Italico University of Rome), Maria De Carluccio(Università Cattolica del Sacro Cuore), Cinzia Volonté(Fondazione Santa Lucia), Vincenzo Romano Spica(Foro Italico University of Rome), Susanna Amadio(Fondazione Santa Lucia), Rosa Di Liddo(University of Padua), Francesco Ria(Università Cattolica del Sacro Cuore)
Cited by 25
Related Papers
Sedentary Behaviors and Physical Activity of Italian Undergraduate Students during Lockdown at the Time of CoViD−19 Pandemic
|International Journal of Environmental Research and Public Health|2020|290
Identification of a<i>SUFU</i>germline mutation in a family with Gorlin syndrome
|American Journal of Medical Genetics Part A|2009|188
Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia
|Brain Research Reviews|2005|151
Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation
|Cell Death and Disease|2013|151
MicroRNA-125b regulates microglia activation and motor neuron death in ALS
|Cell Death and Differentiation|2016|141